Pfizer Inc
NYSE: PFE
$24.96
+$0.16 (+0.6%)
Real Time Data Delayed 15 Min.
PFE Articles
Earnings season is still running strong and the economic readings keep coming out as well. As we come to the end of October, there is going to be plenty of news coming down the pipe. We also have...
Published:
Last Updated:
Short sellers moved out of stocks that have fallen recently. Perhaps they believe there will be a large rally in the market. There is little else to make the shares of companies with poor earnings...
Published:
Novartis (NYSE: NVS) said it would cut 2,000 workers and outsource some functions to companies that will do the work for less than it can. Novartis will take a restructuring charge of $300 million....
Published:
A company can spend billions of dollars on R&D and get little respect as an innovator. Even though that is the conclusion of a new study by Booz & Co., the conclusion is misleading. Booz...
Published:
Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better than analysts expected, but worries persist that the company will be hit...
Published:
Last Updated:
Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent new on the coming flu season, lower rates of prescription writing, and more...
Published:
Last Updated:
The 30-Year Treasury auction, the so-called Long Bond, had a strong participation for what is technically a 29-year and 11-month bond. The participation rate was strong enough that this still shows...
Published:
Last Updated:
These are some of this Wednesday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls. Alkermes, Inc. (NASDAQ: ALKS) Removed from US 1 List but...
Published:
Last Updated:
A new heart drug aimed a reducing the risk of strokes has outperformed the current drug of choice, warfarin, in a study that shows it lowers risk from a type of arrhythmia by 21% and lowers bleeding...
Published:
Last Updated:
LG Display (NYSE: LPL) cuts capital expenditures as demand for LCD screens is hurt by tablet PC sales. (Reuters) Samsung to delay its tablet launch in the U.S. because of IP lawsuits from Apple...
Published:
Active traders and day traders have many stocks to choose from this Tuesday morning. We are tracking news and moves in shares of ARM Holdings (NASDAQ: ARMH), General Electric Company (NYSE:...
Published:
Once patent protection expires on a prescription drug, the drug’s maker can take a serious beating in revenue and profitability. One way to make up for the loss is to get US Food & Drug...
Published:
Hitachi and Mitsubishi may merge (Reuters) Japan intervened in the yen (Reuters) Spain will offer bonds and the European Central Bank meets to examine option to help the country’s debt problems...
Published:
Merck & Co. Inc. (NYSE: MRK) released second-quarter results last Friday and Pfizer Inc. (NYSE: PFE) reported this morning. The results of both drug behemoths are largely in line with analysts...
Published:
We have another very busy earnings week ahead for the second quarter reporting season. Some are DJIA components and some are sector-movers or market-movers. We are tracking earnings and giving...
Published:
Last Updated: